RAC 2.92% $1.94 race oncology ltd

Ann: FDA RPD Designation Granted for RC220 Bisantrene, page-10

  1. 871 Posts.
    lightbulb Created with Sketch. 1076
    Another great piece of news from the @RaceOncology team.

    All these announcements just further add to the attractiveness of RAC to a big pharma one day !
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.